Skip to content

Oral versus Intravenous Paracetamol for Early Postoperative Pain After Percutaneous Nephrolithotomy: A Randomized Controlled Trial

Oral versus Intravenous Paracetamol for Early Postoperative Pain After Percutaneous Nephrolithotomy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260715004
Enrollment
90
Registered
2026-07-15
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative Kidney Calculi Percutaneous Nephrolithotomy Paracetamol Acetaminophen Postoperative Pain Oral Administration Intravenous Administration Analgesia Randomized Controlled Trial

Interventions

Participants received 1 g of intravenous paracetamol diluted in 100 mL solution. The intervention was administered 30 minutes after completion of percutaneous nephrolithotomy and every 8 hours thereaf
Active Comparator Drug,Active Comparator Drug
Intravenous Paracetamol,Oral Paracetamol

Sponsors

This study received no external funding. The study was funded by the authors.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older 2. Scheduled to undergo percutaneous nephrolithotomy 3. American Society of Anesthesiologists physical status classification I or II 4. Able to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Active or inadequately controlled urinary tract infection 2. Pregnancy 3. Suspected malignancy involving the kidney or anticipated access tract 4. Bleeding disorder 5. Substance abuse 6. Known hypersensitivity to paracetamol or ketorolac 7. Hepatic dysfunction, defined as serum transaminase levels greater than twice the upper limit of normal 8. Impaired renal function, defined as serum creatinine greater than 1.5 mg/dL 9. Current use of monoamine oxidase inhibitors or discontinuation within the previous two weeks 10. Medical or psychiatric conditions limiting reliable communication 11. Pre-existing pain-related or neurologic conditions that could interfere with postoperative 12. Numeric Rating Scale assessment, including neuropathy or diabetes mellitus 13. Use of nonsteroidal anti-inflammatory drugs or other analgesic medications within 12 hours before study drug administration

Design outcomes

Primary

MeasureTime frame
Mean postoperative pain score 0 to 24 hours after surgery Mean Numeric Rating Scale pain score during the first 24 hours after percutaneous nephrolithotomy

Secondary

MeasureTime frame
Pain score 1, 4, 8, 12, 16, 20, and 24 hours after surgery Numeric Rating Scale pain score measured at 1, 4, 8, 12, 16, 20, and 24 hours after percutaneous nephrolithotomy,Peak pain score 0 to 24 hours after surgery Highest Numeric Rating Scale pain score recorded during the first 24 hours after percutaneous nephrolithotomy,Rescue analgesia requirement 0 to 24 hours after surgery Requirement for intravenous ketorolac rescue analgesia during the first 24 postoperative hours,Postoperative fever Postoperative day 1 Presence of postoperative fever recorded after percutaneous nephrolithotomy,Hemoglobin drop Postoperative day 1 Difference between preoperative and postoperative hemoglobin levels,Postoperative leukocyte count Postoperative day 1 Leukocyte count measured from postoperative laboratory assessment,Operative duration Intraoperative Duration of percutaneous nephrolithotomy procedure in minutes,Stone-free status Intraoperative Operator-assessed stone-free status after stone removal

Countries

Indonesia

Contacts

Public ContactDaniel Amartya

Department of Urology University of Indonesia Hospital

danielamartya@gmail.com82113318663

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026